• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型纤溶酶原激活物受体(uPAR)与血管内皮生长因子受体2(VEGFR2)的相互作用促进了血管内皮生长因子(VEGF)诱导的血管生成。

The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.

作者信息

Herkenne Stéphanie, Paques Cécile, Nivelles Olivier, Lion Michelle, Bajou Khalid, Pollenus Thomas, Fontaine Marie, Carmeliet Peter, Martial Joseph A, Nguyen Ngoc-Quynh-Nhu, Struman Ingrid

机构信息

Molecular Angiogenesis Laboratory, GIGA Research, University of Liège, Avenue de l'Hôpital, 1, 4000 Liège, Belgium. Dulbecco-Telethon Institute, Venetian Institute of Molecular Medicine, Via Orus 2, 35129 Padova, Italy. Department of Biology, University of Padova, Via U. Bassi 58B, 35121 Padova, Italy.

Molecular Angiogenesis Laboratory, GIGA Research, University of Liège, Avenue de l'Hôpital, 1, 4000 Liège, Belgium.

出版信息

Sci Signal. 2015 Nov 17;8(403):ra117. doi: 10.1126/scisignal.aaa2403.

DOI:10.1126/scisignal.aaa2403
PMID:26577922
Abstract

In endothelial cells, binding of vascular endothelial growth factor (VEGF) to the receptor VEGFR2 activates multiple signaling pathways that trigger processes such as proliferation, survival, and migration that are necessary for angiogenesis. VEGF-bound VEGFR2 becomes internalized, which is a key step in the proangiogenic signal. We showed that the urokinase plasminogen activator receptor (uPAR) interacted with VEGFR2 and described the mechanism by which this interaction mediated VEGF signaling and promoted angiogenesis. Knockdown of uPAR in human umbilical vein endothelial cells (HUVECs) impaired VEGFR2 signaling, and uPAR deficiency in mice prevented VEGF-induced angiogenesis. Upon exposure of HUVECs to VEGF, uPAR recruited the low-density lipoprotein receptor-related protein 1 (LRP-1) to VEGFR2, which induced VEGFR2 internalization. Thus, the uPAR-VEGFR2 interaction is crucial for VEGF signaling in endothelial cells.

摘要

在内皮细胞中,血管内皮生长因子(VEGF)与受体VEGFR2结合会激活多种信号通路,这些信号通路会触发诸如增殖、存活和迁移等血管生成所必需的过程。与VEGF结合的VEGFR2会发生内化,这是促血管生成信号中的关键步骤。我们发现尿激酶型纤溶酶原激活物受体(uPAR)与VEGFR2相互作用,并描述了这种相互作用介导VEGF信号传导和促进血管生成的机制。在人脐静脉内皮细胞(HUVECs)中敲低uPAR会损害VEGFR2信号传导,而小鼠中的uPAR缺陷会阻止VEGF诱导的血管生成。当HUVECs暴露于VEGF时,uPAR会将低密度脂蛋白受体相关蛋白1(LRP-1)募集到VEGFR2,从而诱导VEGFR2内化。因此,uPAR-VEGFR2相互作用对于内皮细胞中的VEGF信号传导至关重要。

相似文献

1
The interaction of uPAR with VEGFR2 promotes VEGF-induced angiogenesis.尿激酶型纤溶酶原激活物受体(uPAR)与血管内皮生长因子受体2(VEGFR2)的相互作用促进了血管内皮生长因子(VEGF)诱导的血管生成。
Sci Signal. 2015 Nov 17;8(403):ra117. doi: 10.1126/scisignal.aaa2403.
2
Necl-5/poliovirus receptor interacts with VEGFR2 and regulates VEGF-induced angiogenesis.Necl-5/poliovirus 受体与 VEGFR2 相互作用,调节 VEGF 诱导的血管生成。
Circ Res. 2012 Mar 2;110(5):716-26. doi: 10.1161/CIRCRESAHA.111.256834. Epub 2012 Jan 26.
3
VEGF-induced endothelial cell migration requires urokinase receptor (uPAR)-dependent integrin redistribution.VEGF 诱导的内皮细胞迁移需要尿激酶受体 (uPAR) 依赖性整合素重分布。
Cardiovasc Res. 2012 Apr 1;94(1):125-35. doi: 10.1093/cvr/cvs017. Epub 2012 Jan 26.
4
Domain 2 of uPAR regulates single-chain urokinase-mediated angiogenesis through β1-integrin and VEGFR2.uPAR 的结构域 2 通过β1 整合素和 VEGFR2 调节单链尿激酶介导的血管生成。
Am J Physiol Heart Circ Physiol. 2013 Aug 1;305(3):H305-20. doi: 10.1152/ajpheart.00110.2013. Epub 2013 May 24.
5
Urokinase-type Plasminogen Activator (uPA) Promotes Angiogenesis by Attenuating Proline-rich Homeodomain Protein (PRH) Transcription Factor Activity and De-repressing Vascular Endothelial Growth Factor (VEGF) Receptor Expression.尿激酶型纤溶酶原激活剂(uPA)通过减弱富含脯氨酸的同源结构域蛋白(PRH)转录因子活性和解除对血管内皮生长因子(VEGF)受体表达的抑制来促进血管生成。
J Biol Chem. 2016 Jul 15;291(29):15029-45. doi: 10.1074/jbc.M115.678490. Epub 2016 May 4.
6
Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.ARF6在血管内皮生长因子诱导的信号传导和血管生成中的新作用。
Circ Res. 2005 Mar 4;96(4):467-75. doi: 10.1161/01.RES.0000158286.51045.16. Epub 2005 Feb 3.
7
Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk.间充质基质细胞通过 uPA-uPAR/VEGFR2/整合素/NOTCH 相互作用增强 HUVEC 管状网络的自组装。
Biochim Biophys Acta Mol Cell Res. 2022 Jan;1869(1):119157. doi: 10.1016/j.bbamcr.2021.119157. Epub 2021 Oct 4.
8
The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.尿激酶型纤溶酶原激活物的重组kringle 结构域通过抑制 VEGFR2 二聚化和随后的信号转导抑制 VEGF165 诱导的 HUVECs 血管生成。
IUBMB Life. 2012 Mar;64(3):259-65. doi: 10.1002/iub.604. Epub 2012 Jan 18.
9
Gαi1 and Gαi3mediate VEGF-induced VEGFR2 endocytosis, signaling and angiogenesis.Gαi1 和 Gαi3 介导 VEGF 诱导的 VEGFR2 内吞作用、信号转导和血管生成。
Theranostics. 2018 Sep 9;8(17):4695-4709. doi: 10.7150/thno.26203. eCollection 2018.
10
Syntenin promotes VEGF-induced VEGFR2 endocytosis and angiogenesis by increasing ephrin-B2 function in endothelial cells.Syntenin通过增强内皮细胞中ephrin-B2的功能来促进VEGF诱导的VEGFR2内吞作用和血管生成。
Oncotarget. 2017 Jun 13;8(24):38886-38901. doi: 10.18632/oncotarget.16452.

引用本文的文献

1
The role of IGF-2 and its variants in enhancing endothelial migration and angiogenesis.胰岛素样生长因子-2(IGF-2)及其变体在促进内皮细胞迁移和血管生成中的作用。
Front Cell Dev Biol. 2025 May 16;13:1598705. doi: 10.3389/fcell.2025.1598705. eCollection 2025.
2
Urokinase-Type Plasminogen Activator Receptor (uPAR) in Inflammation and Disease: A Unique Inflammatory Pathway Activator.尿激酶型纤溶酶原激活物受体(uPAR)在炎症与疾病中的作用:一种独特的炎症途径激活剂
Biomedicines. 2024 May 24;12(6):1167. doi: 10.3390/biomedicines12061167.
3
Multicompartment duct platform to study epithelial-endothelial crosstalk associated with lung adenocarcinoma.
用于研究与肺腺癌相关的上皮-内皮细胞间相互作用的多室导管平台。
APL Bioeng. 2024 Jun 17;8(2):026126. doi: 10.1063/5.0207228. eCollection 2024 Jun.
4
Endothelial-specific Enhancer as a Cis Element of Regulation by TNF-alpha, IL-1beta, and VEGF.内皮细胞特异性增强子作为 TNF-α、IL-1β 和 VEGF 调节的顺式元件。
Curr Pharm Des. 2024;30(21):1630-1640. doi: 10.2174/0113816128296376240424072322.
5
Human antibody V domains targeting uPAR as candidate therapeutics for cancers.靶向尿激酶型纤溶酶原激活物受体(uPAR)的人源抗体V结构域作为癌症的候选治疗药物。
Front Oncol. 2023 Oct 9;13:1194972. doi: 10.3389/fonc.2023.1194972. eCollection 2023.
6
Endothelial Senescence and Its Impact on Angiogenesis in Alzheimer's Disease.阿尔茨海默病中的血管内皮衰老及其对血管生成的影响。
Int J Mol Sci. 2023 Jul 12;24(14):11344. doi: 10.3390/ijms241411344.
7
The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression.uPA/uPAR 系统在纤维化进展中协调炎症反应、血管稳态和免疫系统。
Int J Mol Sci. 2023 Jan 16;24(2):1796. doi: 10.3390/ijms24021796.
8
Modified Benzoxazole-Based VEGFR-2 Inhibitors and Apoptosis Inducers: Design, Synthesis, and Anti-Proliferative Evaluation.基于苯并恶唑的 VEGFR-2 抑制剂和凋亡诱导剂的修饰:设计、合成与抗增殖活性评价。
Molecules. 2022 Aug 8;27(15):5047. doi: 10.3390/molecules27155047.
9
Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.尿激酶受体信号传导对细胞功能的调节:一种机制性观点
Front Cell Dev Biol. 2022 Apr 8;10:818616. doi: 10.3389/fcell.2022.818616. eCollection 2022.
10
Urokinase-type plasminogen activator receptor (uPAR) as a therapeutic target in cancer.尿激酶型纤溶酶原激活物受体(uPAR)作为癌症的治疗靶点。
J Transl Med. 2022 Mar 18;20(1):135. doi: 10.1186/s12967-022-03329-3.